Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against [...]
12 events found.
ISV Webinar Series
Events
-
-
-
-
Computational Modelling of Vaccine Responses
SPEAKER Computational Modelling of Vaccine Responses Tal Einav, LaJolla Institute [...]
-
-
Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use
Title: Estimating the impact of vaccines in reducing antimicrobial resistance [...]
-
Development and Clinical Study in Multiple Phase 1 and 2 trials of infectious disease and cancer vaccines based on the MVA platform
Title: Development and Clinical Study in Multiple Phase 1 and [...]
-
-
Vaccines in the Era of Artificial Intelligence
Title: Vaccines in the Era of Artificial Intelligence. Speaker: Rino [...]
-
-
ISV January Webinar
Title: Development of a recombinant influenza vaccine Flublok® Speaker: Manon [...]
-
-
ISV February Webinar
TITLE: HIV Vaccines Beyond Neutralizing Antibodies PRESENTER: Shan Lu, UMASS [...]
-
-
ISV March Webinar
TITLE: Breaking the Cold Chain: The Future of Thermostable Vaccines SPEAKER: [...]
-
-
ISV April Webinar
Speaker: Dr. Baik-Lin Seong, Yonsei University, Korea
-
-
ISV May Webinar
PRESENTER: Nathalie Garcon from N3JConsulting
-
-
ISV June Webinar
PRESENTER: Dr. Jeffrey Cohen, US National Institutes of Health (NIH)
-
-
ISV November Webinar
PRESENTER: Giuseppe Sautto, Cleveland Clinic, USA